戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  large B-cell lymphomas (centroblastic, 96%; immunoblastic, 4%).
2 tion of Epstein-Barr virus-infected B cells [immunoblastic and central nervous system (CNS) lymphoma]
3 rade non-Hodgkin's lymphomas (centroblastic, immunoblastic), but not in low-grade lymphomas (lymphocy
4        The protein is produced in the B cell immunoblastic cell line DS-1, in normal EBV-transformed
5 re composed of a uniform population of large immunoblastic cells with basophilic cytoplasm, centrally
6 SCF), 38 patients with intermediate-grade or immunoblastic high-grade non-Hodgkin's lymphoma who were
7  frequency of the prognostically unfavorable immunoblastic histology has decreased after HAART.
8 uded were diffuse large B cell, mantle cell, immunoblastic large B cell, follicular, posttransplant l
9 le skin sites (trunk, legs, disseminated) or immunoblastic large B-cell histology involving favorable
10                           Group III included immunoblastic large B-cell histology involving unfavorab
11 e lung transplant recipient who developed an immunoblastic lymphoma 4 months after lung transplantati
12 n thus be used safely to prevent EBV-related immunoblastic lymphoma after allogeneic marrow transplan
13 a distinctive morphology bridging large-cell immunoblastic lymphoma and anaplastic large-cell lymphom
14 ve prophylaxis and treatment of EBV-positive immunoblastic lymphoma in immunocompromised patients.
15 n-Barr virus (EBV) causes potentially lethal immunoblastic lymphoma in up to 25% of children receivin
16 lly significant class of AIDS NHL designated immunoblastic lymphoma plasmacytoid (AIDS IBLP) lacks an
17  not receive prophylaxis and developed overt immunoblastic lymphoma responded fully to T-cell infusio
18                    We report the case of a B-immunoblastic lymphoma that developed in a pretransplant
19 newly diagnosed patients with large-cell and immunoblastic lymphoma who participated in prospective c
20  were 42 patients with intermediate-grade or immunoblastic lymphoma who were considered to be high (6
21 ansformed lymphoblastoid cell lines and AIDS immunoblastic lymphoma, and plasma cells, as defined by
22 bset of patients with intermediate-grade and immunoblastic lymphoma, the 3-year DFS was 89% (95% CI,
23 zation is consistent with that of large cell immunoblastic lymphoma.
24 h Working Formulation intermediate grade and immunoblastic lymphomas (exclusive of mantle cell) and s
25 sistent with previous findings in large cell immunoblastic lymphomas and indicates that this enzyme m
26 mphoma and most high-grade tumors, including immunoblastic lymphomas, expressed minimal amounts of hs
27 s, showed them to be most closely related to immunoblastic lymphomas, less so to plasmacytomas of Fas
28 c appearance of high-grade anaplastic/B-cell immunoblastic lymphomas, with loss of B-cell differentia
29 tologic subgroup, the large-cell diffuse and immunoblastic lymphomas.
30 iferative disorders to aggressive monoclonal immunoblastic lymphomas.
31 y also are B cell lymphomas, usually exhibit immunoblastic morphology, and contain Epstein-Barr virus
32 so found in cases with diffuse large cell or immunoblastic morphology.
33 one of three histologic subtypes: large-cell immunoblastic, small non-cleaved cell (Burkitt's or Burk
34 rwise specified (PTCL-NOS; n = 26) and angio-immunoblastic T-cell lymphoma (AITL; n = 46) patients tr

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。